Bibliografía (cont):

16-Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am. 2005 Mar; 34(1):49-62.

17- Pladevall M,  Singal  B,  Keoki Williams L,  Brotons  C, Guyer H, Sadurni J, Falces C, Serrano-Rios C, Gabriel  R, Shaw JE,  Zimmet PZ,  Haffner SM. A Single Factor Underlies the Metabolic Syndrome. A confirmatory factor analysis. Diabetes Care. 2006; 29:113-122.

18- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2006 Jan; 21(1):1-6.

19-Nassif Hadad A. Claro López, Espinosa Oliva R, Síndrome X en pacientes dislipidémicos, Rev Clínica Invest. Ateroesclerosis 1997;4(9): 143-450.

20- American Diabetes Association. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 2001; 24(Suppl 1):S33-43

21- Blommgarden ZT. 2nd International Symposium on Triglycerides and HDL: Metabolic Syndrome. Diabetes Care. 2005;28(10):2577-2584.

22- Blommgarden ZT. 2nd International Symposium on Triglycerides and HDL: lipid abnormalities and their treatment. Diabetes Care. 2005;28(11):2795-802.

23- Finkelstein J, Joshi A, Hise MK. Association of physical activity and renal function in subjects with and without metabolic syndrome: a review of the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006 Sep; 48(3):372-82.

24- Choi HS, Ryu SH, Lee KB. The relationship of microalbuminuria with metabolic syndrome. Nephron Clin Pract. 2006;104(2):c85-93.

25- Chobanian AV, Bakies GL, Black HR, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressures The JNC 7 Report. JAMA. 2003;289:2580

26-Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B. Frecuency of the WHO metabolic syndrome in Europeans cohorts, and alternative definition of and insulin resistance syndrome. Diabetes and metabolism, 2002; 28: 364-376.

27- Zarti C, Gallagher J The metabolic syndrome. Prevalence, CHD risk and treatment. Journal of Diabetes and Its Complications. 2006; 20: 121-132.

28- Speakman JR. Thrifty genes for obesity and metabolic syndrome- time to call off the search? Diab Vasc Dis Res. 2006; 3(1):5-6

29- Franks S. Genetic and environmental origins of obesity relevant to reproduction. Reprod Biomed Online. 2006 May;12(5):526-31.

30- Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod Biomed Online. 2006 May;12(5):542-51.

31- Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr. 2006; 83(1):47-51.

32- Ebinc H, Ebinc FA, Ozkurt ZN, Dogru T, Yilmaz M. Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals. Acta Cardiol. 2006; 61(4):398-405.

33- Hernandez del Rey R, Armario P, Martin-Baranera M, Castellanos P. Clustering of cardiovascular risk factors and prevalence of metabolic syndrome

in subjects with resistant hypertension Med Clin (Barc). 2006; 127(7):241-5.

34- Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G,

Mannarino E. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension. 2006; 47(5):881-6.

35- Palmieri V, Bella JN. Metabolic syndrome and left ventricular structure and functional abnormalities.    Am J Hypertens. 2006; 19(2):199-205.

36- Vazquez Vigoa A, Vazquez Cruz A, Calderin RO, Buchaca EF, Cruz Alvarez NM,Jimenez Paneque R, Luno J. .Metabolic syndrome in patients with essential hypertension. Nefrologia.  2003 Sep-Oct; 23(5):423-31. 

37- Zavaroni I, Ardigo D, Zuccarelli A, Pacetti E, Piatti PM, Monti L, Valtuena S,

Massironi P, Rossi PC, Reaven GM. Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutr Metab Cardiovasc Dis. 2006; 16(1):22-7.

38- Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance Síndrome: Atherothrombosis disease. Diabetes Care 2006; 29(8): 1973-80

39- Bloomgarden ZT. Cardiovascular disease. Diabetes Care 2006; 29(5):1160-1166.

40- Reaven GM, Scott EM, Grant PJ, Lowe GD, Rumley A, Wannamethee SG, Stratmann B,Tschoepe D, Blann A, Juhan-Vague I, Alessi MC, Bailey C. Hemostatic abnormalities associated with obesity and the metabolic syndrome. J Thromb Haemost. 2005 May; 3(5):1074-85.

41- Ardigo D, Numeroso F, Valtuena S, Franzini L, Piatti PM, Monti L, Delsignore R, Reaven GM, Zavaroni I. Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal  transaminase concentrations. Metabolism. 2005 Dec; 54(12):1566-70.

42- Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005 Aug; 16(4):421-7.

43- Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin resistance. Eur J Gastroenterol Hepatol. 2005 Aug; 17(8):823-6.

44- Miranda PJ. DeFronzo RA. Califf RM, Guyton JR. Metabolic syndrome: Evaluation of pathological and therapeutic outcomes. Am  Heart J 2005; 149:20-32.

45- Mericq V. Prematurity and insulin sensitivity. Horm Res.2006; 65(3):131-6. 

46- Ong KK. Size at birth, postnatal growth and risk of obesity. Horm Res. 2006; 65 (3):65-9.

47- Goran M I, Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. American Journal of Clinical Nutrition. 2001; 2(73):158-171.

48- Caprio S, Genel M. Confronting the epidemic of childhood obesity. Pediatrics. 2005; 115(2):494-5.

49-Smith S, Heron A. Diabetes and Obesity: the twin epidemics. Nature Medicine. 2005; 12(1):75-80.

50- Steinberger J. Diagnosis of the metabolic syndrome in children. Current Opinion in Lipidology 2003;14: 555-59.

51- Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel  III definitions of metabolic syndrome among adolescents. J Pediatr. 2004; 145(4):445-51.

52- Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the  Third  National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356-9.

53- Park  YW, Zhu S,  Palaniappan  L, Heshka S, Carnethon MR, Heymsfield  SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third  National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-36.

54- Isomaa B, Almgrem P, Tuomi T, Forsén B, Lhati K, Nissén M, Taskinen M, Groop L. Cardiovascular morbility and mortality associated with the Metabolic Syndrome, Diabetes Care 2001;24:683-89

55- Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001; 104: 517-29.

56- Bonora E, Kiecchl, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study . Diabetes 1998; 1643-9.

57- Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance Syndrome: associated conditions. Diabetes Care. 2006; 29(9):2165-74.

58- Luque Otero-M, Martell Claros N. Hipertensión arterial y síndrome metabólico. Med Clin (Barc) 2004; 123(18): 707-11

59- Banegas JR, SeguraJ, Ruilope LM, Luque M, García –Robles R, Campo C, et al. Blood pressure control and physician management  of hypertension in hospital hypertension units in Spain. Hypertension  2004; 43: 1338-44.

60- Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006; 83(6):1237-47.

61- Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004; 110(2):e7-12.

62- Marshall MC Jr. Diabetes in African Americans. Postgrad Med J. 2005; 81(962):734-40.

63- Campo C, García Puig J, Segura J, Alcazar JM, García- Robles R, Ruilope LM. Relación entre la gravedad de la hipertensión arterial esencial y la prevalencia de hiperuricemia. Med Clin 2001; 117(93): 85-89.

64- Milionis HJ, Kalantzi HJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum Uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects. Journal of Internal Medicine 2005; 258: 435-441.

65- Bloomgarden ZT.Inflammation, Atherosclerosis, and Aspects of Insulin Action. Diabetes Care. 2005;28(9):2312-19.